Clinical Trial

Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes

Study acronym: MODIFY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
MODIFY study is a multi-centre prospective, longitudinal, observational cohort study which aims to recruit 150 adult patients with type 2 diabetes recruited from community, primary care or secondary care settings. The total length of the study is 75 months. The aim of the study is to develop an MRI-based method to identify whom amongst people with Type 2 diabetes are at risk of further complications in their kidney, liver and cardiovascular system.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2019-10-01; most recent amendment 2025-11-27.
Status change: Recruiting → Active, Not Recruiting 2022-03-22
Status change: Not Yet Recruiting → Recruiting 2020-03-03
Trial Details
NCT Number NCT04114682
Lead Sponsor Perspectum
Collaborators: University of Liverpool, Liverpool University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Trust, Royal Free Hospital NHS Foundation Trust
Conditions Type 2 Diabetes
Enrollment 135 participants
Start Date 2020-01-27
Primary Completion 2025-03-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-01